Going Live Today at 6PM: Know what opportunities India's growth story can create for you and more
Here is the latest financial fact sheet of TTK HEALTHCARE. For more details, see the TTK HEALTHCARE quarterly results and TTK HEALTHCARE share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 12.7 |
No. of shares | m | 7.77 |
% ch week | % | 38.6 |
% ch 1-mth | % | 32.6 |
% ch 12-mth | % | 55.0 |
52 week H/L | Rs | 669.8/388.0 |
No. of Mths Year Ending |
12 Mar-15 |
12 Mar-16 |
12 Mar-17 |
12 Mar-18 |
12 Mar-19 |
5-Yr Chart Click to enlarge
|
---|
TTK HEALTHCARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,118 | 1,259 | 1,110 | 1,458 | 1,215 | |
Low | Rs | 499 | 838 | 770 | 795 | 610 | |
Sales per share (Unadj.) | Rs | 621.5 | 667.8 | 679.3 | 408.7 | 444.4 | |
Earnings per share (Unadj.) | Rs | 20.8 | 29.2 | 24.1 | 12.9 | 17.2 | |
Diluted earnings per share | Rs | 20.8 | 29.2 | 24.1 | 23.4 | 31.4 | |
Cash flow per share (Unadj.) | Rs | 28.7 | 38.5 | 39.5 | 23.6 | 27.6 | |
Dividends per share (Unadj.) | Rs | 4.50 | 5.00 | 5.00 | 5.00 | 5.00 | |
Adj. dividends per share | Rs | 4.50 | 5.00 | 5.00 | 9.09 | 9.09 | |
Dividend yield (eoy) | % | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | |
Book value per share (Unadj.) | Rs | 152.2 | 175.3 | 202.7 | 164.9 | 177.9 | |
Adj. book value per share | Rs | 152.2 | 175.3 | 202.7 | 299.8 | 323.6 | |
Shares outstanding (eoy) | m | 7.77 | 7.77 | 7.77 | 14.13 | 14.13 | |
Bonus/Rights/Conversions | - | - | - | IS | - | ||
Price / Sales ratio | x | 1.3 | 1.6 | 1.4 | 2.8 | 2.1 | |
Avg P/E ratio | x | 38.9 | 35.9 | 39.0 | 87.6 | 52.9 | |
P/CF ratio (eoy) | x | 28.2 | 27.3 | 23.8 | 47.6 | 33.0 | |
Price / Book Value ratio | x | 5.3 | 6.0 | 4.6 | 6.8 | 5.1 | |
Dividend payout | % | 21.7 | 17.1 | 20.7 | 38.9 | 29.0 | |
Avg Mkt Cap | Rs m | 6,282 | 8,147 | 7,304 | 15,916 | 12,894 | |
No. of employees | `000 | 1.8 | 1.8 | 1.9 | 2.2 | 2.3 | |
Total wages/salary | Rs m | 719 | 814 | 880 | 1,201 | 1,307 | |
Avg. sales/employee | Rs Th | 2,669.6 | 2,855.6 | 2,848.4 | 2,573.8 | 2,715.7 | |
Avg. wages/employee | Rs Th | 397.6 | 448.1 | 474.9 | 535.3 | 565.3 | |
Avg. net profit/employee | Rs Th | 89.3 | 124.8 | 101.1 | 81.0 | 105.4 |
TTK HEALTHCARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,829 | 5,189 | 5,278 | 5,776 | 6,279 | |
Other income | Rs m | 66 | 56 | 57 | 76 | 78 | |
Total revenues | Rs m | 4,895 | 5,245 | 5,335 | 5,851 | 6,356 | |
Gross profit | Rs m | 295 | 405 | 385 | 426 | 496 | |
Depreciation | Rs m | 61 | 72 | 119 | 152 | 147 | |
Interest | Rs m | 36 | 33 | 31 | 47 | 34 | |
Profit before tax | Rs m | 263 | 355 | 292 | 302 | 393 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 102 | 129 | 104 | 120 | 149 | |
Profit after tax | Rs m | 162 | 227 | 187 | 182 | 244 | |
Gross profit margin | % | 6.1 | 7.8 | 7.3 | 7.4 | 7.9 | |
Effective tax rate | % | 38.7 | 36.2 | 35.8 | 39.7 | 37.9 | |
Net profit margin | % | 3.3 | 4.4 | 3.6 | 3.1 | 3.9 |
TTK HEALTHCARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,661 | 1,743 | 1,666 | 2,556 | 2,717 | |
Current liabilities | Rs m | 1,291 | 1,520 | 1,197 | 1,675 | 1,571 | |
Net working cap to sales | % | 7.7 | 4.3 | 8.9 | 15.3 | 18.3 | |
Current ratio | x | 1.3 | 1.1 | 1.4 | 1.5 | 1.7 | |
Inventory Days | Days | 28 | 29 | 30 | 33 | 32 | |
Debtors Days | Days | 34 | 26 | 24 | 35 | 47 | |
Net fixed assets | Rs m | 976 | 1,071 | 995 | 1,103 | 991 | |
Share capital | Rs m | 78 | 78 | 78 | 141 | 141 | |
"Free" reserves | Rs m | 1,105 | 1,284 | 1,497 | 2,188 | 2,373 | |
Net worth | Rs m | 1,183 | 1,362 | 1,575 | 2,330 | 2,514 | |
Long term debt | Rs m | 160 | 11 | 9 | 7 | 3 | |
Total assets | Rs m | 2,752 | 2,998 | 2,849 | 4,073 | 4,158 | |
Interest coverage | x | 8.2 | 11.7 | 10.4 | 7.4 | 12.6 | |
Debt to equity ratio | x | 0.1 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.8 | 1.7 | 1.9 | 1.4 | 1.5 | |
Return on assets | % | 7.2 | 8.7 | 7.7 | 5.6 | 6.7 | |
Return on equity | % | 13.7 | 16.6 | 11.9 | 7.8 | 9.7 | |
Return on capital | % | 22.3 | 28.3 | 20.4 | 14.9 | 16.9 | |
Exports to sales | % | 0.7 | 0.8 | 1.0 | 3.0 | 3.6 | |
Imports to sales | % | 2.3 | 1.2 | 1.0 | 0.6 | 0.5 | |
Exports (fob) | Rs m | 33 | 44 | 53 | 172 | 225 | |
Imports (cif) | Rs m | 112 | 63 | 54 | 35 | 31 | |
Fx inflow | Rs m | 33 | 44 | 53 | 172 | 225 | |
Fx outflow | Rs m | 131 | 73 | 69 | 55 | 71 | |
Net fx | Rs m | -97 | -30 | -16 | 117 | 154 |
TTK HEALTHCARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 394 | 374 | 178 | 253 | 173 | |
From Investments | Rs m | -491 | -267 | 53 | -226 | 97 | |
From Financial Activity | Rs m | 29 | -108 | -229 | -72 | -307 | |
Net Cashflow | Rs m | -68 | -2 | 1 | -41 | -38 |
Share Holding
|
Company Information
|
CHM: T. T. Jagannathan | COMP SEC: S. Kalyanaraman | YEAR OF INC: 1958 | BSE CODE: 507747 | FV (Rs): 10 | DIV YIELD (%): 1.3 |
Read: TTK HEALTHCARE 2018-19 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: J.B.CHEMICALS GSK PHARMA CADILA HEALTHCARE NOVARTIS GLENMARK PHARMA
Compare TTK HEALTHCARE With: J.B.CHEMICALS GSK PHARMA CADILA HEALTHCARE NOVARTIS GLENMARK PHARMA
Compare TTK HEALTHCARE With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 17 points, flat at 48,064 levels.
For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
In this video I tell you the three Nifty ETFs I think are the best.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More